glp-1 obesity drug news today oct 23 2025 CVS deal puts Lilly on equal footing with Novo New oral GLP-1 drug delivers
Description
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
Medicare has never paid for weight-loss drugs at scale
Ozempic vs Mounjaro: which GLP-1 delivers more weight loss
It is a monosaccharide, which means it is a single sugar molecule
Improve digestion, energy, and nutrient absorptiondoctor-formulated
This and other trials have shown improvements in patients lipid profiles with the most pronounced impact on reduction of triglycerides
